Abitbol, V.
171  results:
Search for persons X
?
1

P1071 Patient preferences for adalimumab in inflammatory bo..:

Caron, B ; Seksik, P ; Buisson, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1925-i1925 , 2024
 
?
3

P884 Patient satisfaction and experience after a switch to ..:

Bouguen, G ; Gossec, L ; Abitbol, V...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1627-i1627 , 2024
 
?
4

P903 Persistence, efficacy and tolerance of subcutaneous In..:

Mathieu, N ; Heluwaert, F ; Riviere, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1655-i1655 , 2024
 
?
5

P927 Long-term outcomes of risankizumab in Crohn's disease:..:

Fumery, M ; Caron, B ; Hébuterne, X...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1686-i1686 , 2024
 
?
6

DOP89 Impact of biologics on the risk of early postoperativ..:

Fumery, M ; Nancey, S ; Nachury, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i166-i167 , 2023
 
?
7

P443 Risk of incident Cancer in Patients with Inflammatory ..:

Le Cosquer, G ; Gilletta, C ; Amiot, A...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i572-i572 , 2023
 
?
8

P404 Persistence of subcutaneous infliximab after switching..:

Mathieu, N ; Riviere, P ; Heluwaert, F...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i533-i534 , 2023
 
?
9

P638 Effectiveness and safety of risankizumab induction the..:

Fumery, M ; Defrance, A ; Roblin, X...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i770-i770 , 2023
 
?
10

Association entre vascularites des gros vaisseaux et maladi..:

Maillet, F. ; Abitbol, V. ; Allain, J.S....
La Revue de Médecine Interne.  43 (2022)  - p. A126-A127 , 2022
 
?
11

P142 Inflammatory bowel diseases associated with primary im..:

Malamut, G ; Simon, M ; Nachury, M...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i223-i224 , 2022
 
?
12

P350 Comparative risk of incident cancer in patients with I..:

Poullenot, F ; Amiot, A ; Nachury, M...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i362-i363 , 2022
 
?
13

Comparative Risk of Incident Cancer in Patients with Inflam..:

Poullenot, F ; Amiot, A ; Nachury, M...
Journal of Crohn's and Colitis.  16 (2022)  10 - p. 1523-1530 , 2022
 
?
14

P140 Immunomodulators are protective against severe COVID 1..:

Vuitton, L ; Bourrier, A ; Uzzan, M...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i222-i223 , 2022
 
?
15

P504 Effectiveness and safety of ustekinumab maintenance th..:

Fumery, M ; Filippi, J ; Abitbol, V...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S486-S487 , 2021
 
1-15